Investment
Features
FeesSafety
Academy
More
Pluang+

Goldman Sachs offers $100B Treasury fund access on Avalanche blockchain without tokenization

Protocol Fundamentals
28 Sep 2026
Crypto Briefing
View Source
Bullish
Goldman Sachs offers $100B Treasury fund access on Avalanche blockchain without tokenization

Goldman Sachs is making its $100 billion FTIXX Treasury fund accessible to crypto-native institutions via Lynq, a real-time settlement network on a private Avalanche blockchain. Unlike competitors who tokenize funds, Goldman keeps FTIXX as a traditional money-market product, using blockchain only for settlement to streamline access and liquidity for eligible US clients. This approach avoids regulatory complexities tied to tokenization, though it limits the fund's use in DeFi protocols. Lynq's platform already serves over 30 institutional crypto clients, marking a new distribution method for institutional yield generation.

Goldman Sachs' $100 billion FTIXX Treasury fund is introduced to crypto institutions via Lynq on Avalanche. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Sep 29, 2026 02:51 WIB: out of 50 major cryptocurrencies, 10 rose and 39 fell. Notable movers include ONE (Harmony) with a 12.34% gain and a typical hold time of 152 days, COTI down 11.85% with an 80% buy order activity, and BAL (Balancer) up 11.14% with a typical hold time of 85 days.

More News

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...

Market News
Bearish
1 hour ago
Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...

Market News
Bullish
1 hour ago
Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...

Market News
Bullish
2 hours ago
Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

A director of Espey Manufacturing and Electronics Corp sold 100 shares at $64.49 each, reducing his holdings to 20,550 shares. This insider sale happened after the company reported strong 2026 financial results, including net sales growth to $46.1 mi...

Market News
Neutral
2 hours ago
Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts reported Q4 earnings per share of -$5.34, slightly better than expected, with revenue of $278.1 million surpassing estimates. The company benefited from a 5.2% rise in mountain revenues, driven by strong pass sales in Australia and stabl...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App